Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
EBITDA Growth
-102.89%
Quarterly · Period ending:
TEVA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-102.89%period ending
Latest reported-102.89%period ending
TEVA Quarterly EBITDA YoY % (53.07% → -102.89%)
Year-over-year change
High-resolution chart · PNG
TEVA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -7.0716% | |
| 48.6987% | |
| 185.5684% | |
| 14.1411% | |
| 126.8422% | |
| 38.1849% | |
| 34.2375% | |
| 70.6806% | |
| 97.1292% | |
| 15.3153% | |
| 107.0485% | |
| -86.676% | |
| -92.2793% | |
| -87.5561% | |
| -19.0929% | |
| 21.175% | |
| 8.1934% | |
| 41.3629% | |
| -52.0578% | |
| 43.1337% | |
| 59.5663% | |
| 23.9686% | |
| -12.2347% | |
| 15.1916% | |
| 6.7393% | |
| 11.7045% | |
| -13.3357% | |
| 12.8145% | |
| 17.52% | |
| 15.4561% | |
| -29.2048% | |
| 36.7742% | |
| 34.4086% | |
| 27.4489% | |
| -13.7806% | |
| 18.1703% | |
| 19.5373% | |
| 6.4147% | |
| -29.2339% | |
| 25.7188% | |
| 11.7816% | |
| 32.8767% | |
| 1.847% | |
| -1.8809% | |
| 1.1628% | |
| -3.6657% | |
| -24.0589% | |
| 36.9099% | |
| 37.3253% | |
| 36.4% | |
| 63.5088% | |
| 89.7727% | |
| -18.3381% | |
| -24.3553% | |
| 53.0702% | |
| 53.0702% |